BioCentury | Aug 19, 2020
Management Tracks

Rao to head Sobi R&D; plus new CMOs for Ikena, Agile, Nordic Nanovector and more

...same title at Merrimack Pharmaceuticals Inc. (NASDAQ:MACK). Sager will become a consultant to the company.Women’s health company Agile Therapeutics Inc....
...from Cellectis S.A. (Euronext:ALCLS; NASDAQ:CLLS), where he was EVP of technical operations. Robin Sawka Swedish Orphan Biovitrum AB Ikena Oncology Agile Therapeutics Inc. Nordic...
BioCentury | Aug 6, 2019
Company News

Management tracks: Allogene snags Adaptimmune's Amado; plus Foundation Medicine, CymaBay and more

...Solna, Sweden) hired Scott Coiante as SVP and CFO. He was SVP and CFO of Agile Therapeutics Inc....
BioCentury | Jul 1, 2019
Company News

Management Tracks: BioCryst hires its first CBO; plus ObsEva, Veracyte and more

...become VP, head of drug safety and pharmacovigilance. Garner was CMO, SVP clinical development at Agile Therapeutics Inc....
BioCentury | Jun 26, 2019
Company News

June 25 Company Quick Takes: Conatus restructuring; plus Almirall-Dermira, Acer, Glenmark and more

...see "LifeArc Gets $1.3B for Keytruda Royalties" ). FDA committee sets date for Agile's Twirla Agile Therapeutics Inc....
...lambrolizumab) lebrikizumab (MILR1444A, RG3637, tnx-650, anti-IL13) Ryaltris, mometasone/olopatadine (gsp 301) Seven-day contraceptive patch, Twirla (AG200-15, ag-200-15, Agile Patch, estradiol/levonorgestrel) Agile Therapeutics Agile Therapeutics Inc. Almirall Almirall...
BioCentury | Jan 9, 2018
Finance

Stars in China

...for Dsuvia sufentanil sublingual tablet (ARX-04) to treat moderate-to-severe acute pain in medically supervised settings Agile Therapeutics Inc....
BioCentury | Jan 5, 2018
Clinical News

Agile gets second CRL for Twirla

...levonorgestrel. Agile Therapeutics Inc. (NASDAQ:AGRX), Princeton, N.J. Product: Twirla (seven-day contraceptive patch, AG200-15) Business: Endocrine/Metabolic Mary Romeo AG200-15 Seven-day contraceptive patch Twirla Agile Therapeutics Inc. Estrogen...
BioCentury | Dec 22, 2017
Company News

Agile gets second CRL for Twirla

...FDA and identify a path for Twirla's approval. Twirla delivers low-dose ethinyl estradiol and levonorgestrel. Mary Romeo AG200-15 Twirla Agile Therapeutics Inc....
BioCentury | Oct 6, 2017
Finance

High as a Kite

...CSE:ZEAL; NASDAQ:ZEAL) 8/9/17 $89.9 $548.9 $589.8 7% MyoKardia Inc. (NASDAQ:MYOK) 8/8/17 $142.9 $1,260.8 $1,521.8 21% Agile Therapeutics Inc....
BioCentury | Aug 28, 2017
Clinical News

FDA reviewing Agile's resubmitted NDA for contraceptive

...Agile Therapeutics Inc. (NASDAQ:AGRX), Princeton, N.J. Product: Twirla (seven-day contraceptive patch, AG200-15) Business: Endocrine/Metabolic Elizabeth S. Eaton AG200-15 Seven-day contraceptive patch Twirla Agile Therapeutics Inc. Estrogen...
BioCentury | Apr 21, 2017
Clinical News

Twirla: Ph III SECURE data

...for the product. This quarter, Agile plans to resubmit an NDA to FDA for Twirla. Agile Therapeutics Inc....
...as measured by the Pearl Index; safety Status: Phase III data Milestone: Resubmit NDA (2Q17) Chris Lieu AG200-15 Twirla Agile Therapeutics Inc. Estrogen...
Items per page:
1 - 10 of 64
BioCentury | Aug 19, 2020
Management Tracks

Rao to head Sobi R&D; plus new CMOs for Ikena, Agile, Nordic Nanovector and more

...same title at Merrimack Pharmaceuticals Inc. (NASDAQ:MACK). Sager will become a consultant to the company.Women’s health company Agile Therapeutics Inc....
...from Cellectis S.A. (Euronext:ALCLS; NASDAQ:CLLS), where he was EVP of technical operations. Robin Sawka Swedish Orphan Biovitrum AB Ikena Oncology Agile Therapeutics Inc. Nordic...
BioCentury | Aug 6, 2019
Company News

Management tracks: Allogene snags Adaptimmune's Amado; plus Foundation Medicine, CymaBay and more

...Solna, Sweden) hired Scott Coiante as SVP and CFO. He was SVP and CFO of Agile Therapeutics Inc....
BioCentury | Jul 1, 2019
Company News

Management Tracks: BioCryst hires its first CBO; plus ObsEva, Veracyte and more

...become VP, head of drug safety and pharmacovigilance. Garner was CMO, SVP clinical development at Agile Therapeutics Inc....
BioCentury | Jun 26, 2019
Company News

June 25 Company Quick Takes: Conatus restructuring; plus Almirall-Dermira, Acer, Glenmark and more

...see "LifeArc Gets $1.3B for Keytruda Royalties" ). FDA committee sets date for Agile's Twirla Agile Therapeutics Inc....
...lambrolizumab) lebrikizumab (MILR1444A, RG3637, tnx-650, anti-IL13) Ryaltris, mometasone/olopatadine (gsp 301) Seven-day contraceptive patch, Twirla (AG200-15, ag-200-15, Agile Patch, estradiol/levonorgestrel) Agile Therapeutics Agile Therapeutics Inc. Almirall Almirall...
BioCentury | Jan 9, 2018
Finance

Stars in China

...for Dsuvia sufentanil sublingual tablet (ARX-04) to treat moderate-to-severe acute pain in medically supervised settings Agile Therapeutics Inc....
BioCentury | Jan 5, 2018
Clinical News

Agile gets second CRL for Twirla

...levonorgestrel. Agile Therapeutics Inc. (NASDAQ:AGRX), Princeton, N.J. Product: Twirla (seven-day contraceptive patch, AG200-15) Business: Endocrine/Metabolic Mary Romeo AG200-15 Seven-day contraceptive patch Twirla Agile Therapeutics Inc. Estrogen...
BioCentury | Dec 22, 2017
Company News

Agile gets second CRL for Twirla

...FDA and identify a path for Twirla's approval. Twirla delivers low-dose ethinyl estradiol and levonorgestrel. Mary Romeo AG200-15 Twirla Agile Therapeutics Inc....
BioCentury | Oct 6, 2017
Finance

High as a Kite

...CSE:ZEAL; NASDAQ:ZEAL) 8/9/17 $89.9 $548.9 $589.8 7% MyoKardia Inc. (NASDAQ:MYOK) 8/8/17 $142.9 $1,260.8 $1,521.8 21% Agile Therapeutics Inc....
BioCentury | Aug 28, 2017
Clinical News

FDA reviewing Agile's resubmitted NDA for contraceptive

...Agile Therapeutics Inc. (NASDAQ:AGRX), Princeton, N.J. Product: Twirla (seven-day contraceptive patch, AG200-15) Business: Endocrine/Metabolic Elizabeth S. Eaton AG200-15 Seven-day contraceptive patch Twirla Agile Therapeutics Inc. Estrogen...
BioCentury | Apr 21, 2017
Clinical News

Twirla: Ph III SECURE data

...for the product. This quarter, Agile plans to resubmit an NDA to FDA for Twirla. Agile Therapeutics Inc....
...as measured by the Pearl Index; safety Status: Phase III data Milestone: Resubmit NDA (2Q17) Chris Lieu AG200-15 Twirla Agile Therapeutics Inc. Estrogen...
Items per page:
1 - 10 of 64